FRANKLIN LAKES, NJ – Global medical technology company BD (Becton, Dickinson, and Company) announced July 11 that it has entered into a definitive agreement to acquire Safety Syringes, Inc. Safety Syringes is a privately held California-based company specializing in the development of anti-needlestick devices for prefilled syringes.
The acquisition, which is subject to the satisfaction of customary closing conditions, is expected to close by the end of BD’s fiscal year 2012. The financial terms of the agreement were not disclosed.
This would enable BD to provide passive safety offerings to any prefillable syringe customer. Safety Syringes, Inc. is a category leader for passive needle shields and guards for prefilled syringes, supporting more than 20 drugs on the market at present.
"This pending acquisition is well aligned to BD's strategy of applying technology and clinical knowledge to make healthcare more effective, efficient and safe. Developments for parenteral drug delivery systems continue to be a part of BD's long-term strategy. This acquisition is intended to provide our BD Medical - Pharmaceutical Systems unit with additional safety features for prefillable syringes, helping to protect against accidental needlesticks by providing safer injections for healthcare workers and end users,” said William A. Kozy, BD executive vice president.
"We believe BD's prefillable syringe expertise, combined with Safety Syringes' product portfolio and device development expertise, will enable new and innovative safety technology development to prepare the next generation of safety-engineered prefillable syringes," said Claude Dartiguelongue, president, BD Medical - Pharmaceutical Systems.
Mercurial Victory CR7 Low
iConnectHub
Login/Register
Supplier Login















